Meloxicam and Celestone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Celestone (betamethasone). Common drug interactions include chronic kidney disease among females and autoimmune arthritis among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Celestone. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.

What is Celestone?

Celestone has active ingredients of betamethasone. It is often used in bursitis. eHealthMe is studying from 1,788 Celestone users. Check the latest studies of Celestone.



On Jul, 11, 2026

16 people who take Meloxicam and Celestone together, and have interactions are studied.

Meloxicam and Celestone drug interactions.

What are the common drug interactions of Meloxicam and Celestone, by gender? *:

female:

  1. Chronic kidney disease
  2. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  3. Abdominal discomfort
  4. Anaemia (lack of blood)
  5. Blood glucose decreased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cough
  8. Drug ineffective
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

male:

  1. Autoimmune arthritis (joint inflammation)
  2. Tendonitis (a condition that causes pain and swelling of tendons)
  3. Lower limb fracture
  4. Rib fracture
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Skull fractured base
  7. Subcutaneous haematoma (collection of blood outside the blood vessels on the skin)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Anxiety
  10. Blood creatinine increased

What are the common drug interactions of Meloxicam and Celestone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blindness unilateral
  2. Blood glucose decreased
  3. Brain injury
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cough
  6. Deafness unilateral
  7. Drug diversion
  8. Dyspnoea (difficult or laboured respiration)
  9. Facial paralysis (loss of function of face muscle)
  10. Foot fracture

50-59:

  1. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  2. Chronic kidney disease
  3. Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)

60+:

  1. Autoimmune arthritis (joint inflammation)
  2. Tendonitis (a condition that causes pain and swelling of tendons)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Gout (uric acid crystals building up in the body)
  5. Melaena (the passage of black, tarry stools)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Proteinuria (presence of protein in the urine)
  8. Renal failure (kidney dysfunction)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 37.50%
  2. Pain: 5 people, 31.25%
  3. Joint Pain: 4 people, 25.00%
  4. Viral Infection: 3 people, 18.75%
  5. Migraine (headache): 3 people, 18.75%
  6. Asbestosis (chronic lung disease caused by scarring of lung tissue, which stems from prolonged exposure to asbestos): 3 people, 18.75%
  7. Constipation: 3 people, 18.75%
  8. Dehydration (dryness resulting from the removal of water): 3 people, 18.75%
  9. Dyspnea (difficult or laboured breathing): 3 people, 18.75%
  10. Fever: 3 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Celestone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Meloxicam and Celestone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Celestone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meloxicam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celestone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and betamethasone (the active ingredients of Meloxicam and Celestone, respectively), and Meloxicam and Celestone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: